Deutsche Bank’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,344
Closed -$21K 5288
2017
Q3
$21K Buy
2,344
+1,195
+104% +$9.71K ﹤0.01% 4564
2017
Q2
$9K Buy
1,149
+828
+258% +$6.81K ﹤0.01% 4685
2017
Q1
$2K Buy
+321
New +$2.83K ﹤0.01% 4800
2014
Q3
Sell
-1,049
Closed -$8K 6236
2014
Q2
$8K Sell
1,049
-1,500
-59% -$14.8K ﹤0.01% 5562
2014
Q1
$29K Sell
2,549
-1,138
-31% -$12.9K ﹤0.01% 4737
2013
Q4
$46K Buy
+3,687
New +$45K ﹤0.01% 4388

Other funds holding MGCD

Deutsche Bank's MGCD Position: Q4 2017 in Review

Deutsche Bank sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 2,344 shares — an estimated $21K sold.

Deutsche Bank first reported a position in MGCD in Q4 2013 and held it in 6 quarters. The position peaked at $46K in Q4 2013. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

  • Deutsche Bank reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
  • Deutsche Bank sold 2,344 MGC Diagnostics Corporation shares in Q4 2017, an estimated $21K.
  • Deutsche Bank first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 6 quarters.
  • Deutsche Bank's MGC Diagnostics Corporation position peaked at $46K in Q4 2013.
  • 12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.